AU Stock MarketDetailed Quotes

CUV Clinuvel Pharmaceuticals Ltd

Watchlist
  • 12.960
  • 0.0000.00%
20min DelayMarket Closed Dec 4 16:00 AET
648.79MMarket Cap18.57P/E (Static)

Clinuvel Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
(FY)Jun 30, 2015
Total revenue
12.59%88.18M
19.17%78.32M
36.99%65.72M
47.32%47.98M
4.89%32.57M
21.82%31.05M
52.42%25.49M
169.19%16.72M
113.33%6.21M
32.34%2.91M
Operating revenue
12.59%88.18M
19.17%78.32M
36.99%65.72M
47.32%47.98M
4.89%32.57M
21.82%31.05M
52.42%25.49M
169.19%16.72M
113.33%6.21M
32.34%2.91M
Cost of revenue
14.70%10.08M
-16.16%8.79M
122.10%10.48M
-50.98%4.72M
40.14%9.63M
14.80%6.87M
47.68%5.99M
8.52%4.05M
43.48%3.73M
-20.10%2.6M
Gross profit
12.32%78.1M
25.88%69.53M
27.70%55.24M
88.59%43.26M
-5.13%22.94M
23.98%24.18M
53.94%19.5M
411.49%12.67M
702.49%2.48M
129.18%308.61K
Operating expense
18.33%30.09M
27.73%25.43M
32.45%19.91M
30.19%15.03M
49.94%11.55M
4.72%7.7M
23.23%7.35M
-10.42%5.97M
-42.42%6.66M
119.41%11.57M
Selling and administrative expenses
10.89%25.03M
27.41%22.57M
38.81%17.71M
575.61%12.76M
25.75%1.89M
42.89%1.5M
-81.54%1.05M
-10.60%5.69M
-43.68%6.37M
123.62%11.31M
-Selling and marketing expense
----
----
----
----
25.75%1.89M
42.89%1.5M
29.54%1.05M
4.33%811.43K
-2.97%777.73K
55.30%801.56K
-General and administrative expense
10.89%25.03M
27.41%22.57M
38.81%17.71M
--12.76M
----
----
----
-12.68%4.88M
-46.79%5.59M
131.38%10.51M
Depreciation amortization depletion
44.71%1.14M
4.17%789.41K
-12.03%757.83K
101.44%861.43K
99.67%427.63K
380.80%214.16K
-16.17%44.54K
108.17%53.14K
-3.82%25.53K
-29.18%26.54K
-Depreciation and amortization
44.71%1.14M
4.17%789.41K
-12.03%757.83K
101.44%861.43K
99.67%427.63K
380.80%214.16K
-16.17%44.54K
108.17%53.14K
-3.82%25.53K
-29.18%26.54K
Other operating expenses
89.25%3.92M
44.07%2.07M
2.10%1.44M
-84.73%1.41M
54.23%9.23M
-4.37%5.98M
2,747.85%6.26M
-17.42%219.71K
14.61%266.07K
30.78%232.15K
Operating profit
8.85%48.01M
24.83%44.1M
25.18%35.33M
147.79%28.22M
-30.87%11.39M
35.64%16.48M
81.29%12.15M
260.14%6.7M
62.84%-4.18M
-77.87%-11.26M
Net non-operating interest income (expenses)
302.53%2.87M
138.96%713.14K
-43.41%-1.83M
-337.64%-1.28M
-1.20%537.04K
105.54%543.54K
0.02%264.45K
26.89%264.39K
-40.19%208.37K
6.72%348.41K
Non-operating interest income
87.54%7.32M
779.56%3.91M
29.77%444.07K
-39.21%342.2K
-0.31%562.93K
113.52%564.66K
0.02%264.45K
26.89%264.39K
-40.19%208.37K
6.72%348.41K
Non-operating interest expense
39.51%4.45M
40.38%3.19M
40.53%2.27M
6,152.14%1.62M
22.60%25.89K
--21.11K
----
----
----
----
Other net income (expenses)
-125.87%-197.44K
-7.07%763.08K
166.46%821.15K
-258.14%-1.24M
-11.26%781.32K
81.23%880.48K
405.48%485.84K
-87.93%96.11K
69.38%796.53K
6.78%470.27K
Other non-operating income (expenses)
-125.87%-197.44K
-7.07%763.08K
166.46%821.15K
-258.14%-1.24M
-11.26%781.32K
81.23%880.48K
405.48%485.84K
-87.93%96.11K
69.38%796.53K
6.78%470.27K
Income before tax
11.19%50.68M
32.80%45.58M
33.48%34.32M
95.73%25.71M
-27.48%13.14M
39.96%18.11M
81.92%12.94M
325.58%7.11M
69.72%-3.15M
-88.47%-10.41M
Income tax
0.46%15.04M
11.39%14.97M
1,265.55%13.44M
128.04%984.4K
-18,057.49%-3.51M
93.14%-19.33K
-281.78K
0
0
0
Earnings from equity interest net of tax
Net income
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
85.88%13.22M
325.58%7.11M
69.72%-3.15M
-88.47%-10.41M
Net income continuous operations
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
85.88%13.22M
325.58%7.11M
69.72%-3.15M
-88.47%-10.41M
Noncontrolling interests
-66.54K
Net income attributable to the company
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
84.16%13.22M
327.69%7.18M
69.72%-3.15M
-88.47%-10.41M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
84.16%13.22M
327.69%7.18M
69.72%-3.15M
-88.47%-10.41M
Diluted earnings per share
15.51%0.715
46.34%0.619
-15.40%0.423
47.93%0.5
-10.11%0.338
35.74%0.376
85.91%0.277
312.86%0.149
70.83%-0.07
-67.83%-0.24
Basic earnings per share
18.10%0.698
46.65%0.591
-16.74%0.403
46.67%0.484
-9.84%0.33
37.08%0.366
86.71%0.267
304.29%0.143
70.83%-0.07
-67.83%-0.24
Dividend per share
25.00%0.05
60.00%0.04
0.00%0.025
0.00%0.025
25.00%0.025
0.02
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016(FY)Jun 30, 2015
Total revenue 12.59%88.18M19.17%78.32M36.99%65.72M47.32%47.98M4.89%32.57M21.82%31.05M52.42%25.49M169.19%16.72M113.33%6.21M32.34%2.91M
Operating revenue 12.59%88.18M19.17%78.32M36.99%65.72M47.32%47.98M4.89%32.57M21.82%31.05M52.42%25.49M169.19%16.72M113.33%6.21M32.34%2.91M
Cost of revenue 14.70%10.08M-16.16%8.79M122.10%10.48M-50.98%4.72M40.14%9.63M14.80%6.87M47.68%5.99M8.52%4.05M43.48%3.73M-20.10%2.6M
Gross profit 12.32%78.1M25.88%69.53M27.70%55.24M88.59%43.26M-5.13%22.94M23.98%24.18M53.94%19.5M411.49%12.67M702.49%2.48M129.18%308.61K
Operating expense 18.33%30.09M27.73%25.43M32.45%19.91M30.19%15.03M49.94%11.55M4.72%7.7M23.23%7.35M-10.42%5.97M-42.42%6.66M119.41%11.57M
Selling and administrative expenses 10.89%25.03M27.41%22.57M38.81%17.71M575.61%12.76M25.75%1.89M42.89%1.5M-81.54%1.05M-10.60%5.69M-43.68%6.37M123.62%11.31M
-Selling and marketing expense ----------------25.75%1.89M42.89%1.5M29.54%1.05M4.33%811.43K-2.97%777.73K55.30%801.56K
-General and administrative expense 10.89%25.03M27.41%22.57M38.81%17.71M--12.76M-------------12.68%4.88M-46.79%5.59M131.38%10.51M
Depreciation amortization depletion 44.71%1.14M4.17%789.41K-12.03%757.83K101.44%861.43K99.67%427.63K380.80%214.16K-16.17%44.54K108.17%53.14K-3.82%25.53K-29.18%26.54K
-Depreciation and amortization 44.71%1.14M4.17%789.41K-12.03%757.83K101.44%861.43K99.67%427.63K380.80%214.16K-16.17%44.54K108.17%53.14K-3.82%25.53K-29.18%26.54K
Other operating expenses 89.25%3.92M44.07%2.07M2.10%1.44M-84.73%1.41M54.23%9.23M-4.37%5.98M2,747.85%6.26M-17.42%219.71K14.61%266.07K30.78%232.15K
Operating profit 8.85%48.01M24.83%44.1M25.18%35.33M147.79%28.22M-30.87%11.39M35.64%16.48M81.29%12.15M260.14%6.7M62.84%-4.18M-77.87%-11.26M
Net non-operating interest income (expenses) 302.53%2.87M138.96%713.14K-43.41%-1.83M-337.64%-1.28M-1.20%537.04K105.54%543.54K0.02%264.45K26.89%264.39K-40.19%208.37K6.72%348.41K
Non-operating interest income 87.54%7.32M779.56%3.91M29.77%444.07K-39.21%342.2K-0.31%562.93K113.52%564.66K0.02%264.45K26.89%264.39K-40.19%208.37K6.72%348.41K
Non-operating interest expense 39.51%4.45M40.38%3.19M40.53%2.27M6,152.14%1.62M22.60%25.89K--21.11K----------------
Other net income (expenses) -125.87%-197.44K-7.07%763.08K166.46%821.15K-258.14%-1.24M-11.26%781.32K81.23%880.48K405.48%485.84K-87.93%96.11K69.38%796.53K6.78%470.27K
Other non-operating income (expenses) -125.87%-197.44K-7.07%763.08K166.46%821.15K-258.14%-1.24M-11.26%781.32K81.23%880.48K405.48%485.84K-87.93%96.11K69.38%796.53K6.78%470.27K
Income before tax 11.19%50.68M32.80%45.58M33.48%34.32M95.73%25.71M-27.48%13.14M39.96%18.11M81.92%12.94M325.58%7.11M69.72%-3.15M-88.47%-10.41M
Income tax 0.46%15.04M11.39%14.97M1,265.55%13.44M128.04%984.4K-18,057.49%-3.51M93.14%-19.33K-281.78K000
Earnings from equity interest net of tax
Net income 16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M85.88%13.22M325.58%7.11M69.72%-3.15M-88.47%-10.41M
Net income continuous operations 16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M85.88%13.22M325.58%7.11M69.72%-3.15M-88.47%-10.41M
Noncontrolling interests -66.54K
Net income attributable to the company 16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M84.16%13.22M327.69%7.18M69.72%-3.15M-88.47%-10.41M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M84.16%13.22M327.69%7.18M69.72%-3.15M-88.47%-10.41M
Diluted earnings per share 15.51%0.71546.34%0.619-15.40%0.42347.93%0.5-10.11%0.33835.74%0.37685.91%0.277312.86%0.14970.83%-0.07-67.83%-0.24
Basic earnings per share 18.10%0.69846.65%0.591-16.74%0.40346.67%0.484-9.84%0.3337.08%0.36686.71%0.267304.29%0.14370.83%-0.07-67.83%-0.24
Dividend per share 25.00%0.0560.00%0.040.00%0.0250.00%0.02525.00%0.0250.02
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Healthcare - Cancer Research
Healthcare - Cancer Research
Intraday-0.45%